![Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen](https://www.scienceopen.com/document_file/259bfaf9-f5c4-4a79-a86d-fecbb5c3b9bf/PubMedCentral/large.png)
Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen
![Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12070-018-1410-8/MediaObjects/12070_2018_1410_Fig1_HTML.png)
Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink
![β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63994b769f5605779fe9e7f7df1a9629c0ac16b7/19-Figure1-1.png)
β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar
![Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway](https://www.spandidos-publications.com/article_images/mmr/10/1/MMR-10-01-0301-g01.jpg)
Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway
![Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation](https://static.hindawi.com/articles/bmri/volume-2021/6636891/figures/6636891.fig.001b.jpg)
Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
![Enhanced skin delivery of propranolol HCl using nonionic surfactant-based vesicles for topical treatment of infantile hemangioma - ScienceDirect Enhanced skin delivery of propranolol HCl using nonionic surfactant-based vesicles for topical treatment of infantile hemangioma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224720315240-fx1.jpg)
Enhanced skin delivery of propranolol HCl using nonionic surfactant-based vesicles for topical treatment of infantile hemangioma - ScienceDirect
![Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations | Stroke Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations | Stroke](https://www.ahajournals.org/cms/asset/329dac41-65e7-4afb-b1ab-ec06c1f82151/strokeaha.120.029676.fig05.jpg)
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations | Stroke
![Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962210007632-gr1.jpg)
Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect
![Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpr.2013.231/MediaObjects/41390_2014_Article_BFpr2013231_Fig7_HTML.jpg)
Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research
![Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41698-019-0099-9/MediaObjects/41698_2019_99_Fig9_HTML.png)
Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology
![Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram](https://www.researchgate.net/publication/236225663/figure/fig1/AS:203006252458001@1425411870713/Possible-mechanisms-of-action-of-propranolol-in-infantile-hemangiomas-IHs-In-the.png)
Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram
![Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas](https://www.frontiersin.org/files/Articles/427848/fonc-08-00605-HTML/image_m/fonc-08-00605-g001.jpg)
Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
![Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1578219012000315:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Akdb5dOYTvnAx3pNEJrQCCIhIazXPPa2g0UVu+AjbF9kRcGM5sLb1X911Ef9TMVc5cyQfJfY+9CwmVkskVu2+YWltG8Lz6Vc1w4T9ym4MX6yBG9t1/ZXUPbBdJMmaVjFAsRKQJ9EAdmJSwVU2hY/YR9QHP5FB91UUmHbCj5KKqKZLuOL9zeqEL7EOQg6GlhIgW0vyghdW9ZUgKQhx70Oy8w=)
Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas
![The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action - Ji - 2015 - British Journal of Dermatology - Wiley Online Library The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action - Ji - 2015 - British Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/de3a32a0-3d0c-4f72-a032-58f0f1996030/bjd13388-fig-0004-m.jpg)
The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action - Ji - 2015 - British Journal of Dermatology - Wiley Online Library
![JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma](https://dm5migu4zj3pb.cloudfront.net/manuscripts/151000/151109/medium/JCI151109.ga.jpg)